Abingdon Health Plc
Research Abingdon Health Plc (ABDX) on Bullrun: market cap GBX 2.82B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerABDX
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyGBX
- Market capGBX 2.82B
- Financial periodFY2025
- RevenueGBP 8.43M
- Revenue growth37.4%
- Net income-GBP 3.42M
- Free cash flow-GBP 3.53M
- Gross margin44.3%
Valuation Snapshot
latest market cap is GBX 2.82B.
About Abingdon Health Plc
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.
Frequently asked questions
What is Abingdon Health Plc's market cap?
Abingdon Health Plc's market capitalization is GBX 2.82B.
What does Abingdon Health Plc do?
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments.